Remove 2030 Remove Packaging Remove Pharmaceutical Manufacturing
article thumbnail

16th CPHI & PMEC India 2023 redefines pharma landscape

Express Pharma

It provides an unparalleled platform for stakeholders to participate in extensive dialogues covering pharma machinery, packaging, analytical instruments, laboratory technologies, equipment, ancillaries, ingredients, and beyond. Despite challenges in CIS countries, the global reception of Indian pharma remains positive. billion (Rs 2.1

Packaging 110
article thumbnail

16th edition of CPHI & PMEC India Expo to be held from November 28-30, 2023, at India Expo Centre, Greater Noida

Express Pharma

Fette Compacting Machinery India, Ace Technologies & Packaging Systems, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare, Venkata Narayana Active Ingredients, Unilab Chemicals and Pharmaceuticals, and many others. A vaccine manufacturing powerhouse, India leads by supplying over 60 per cent of global vaccine demand.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond

Express Pharma

India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. There have been persistent concerns about AMR being aggravated by effluents from pharmaceutical manufacturing plants.

article thumbnail

Procuring HIV/AIDS medicines from African producers

Quality Matters

To that end, PEPFAR plans to support the scale-up of regional manufacturing by procuring HIV/AIDS health products from African producers, helping to shape markets and bring investors to the table. But that number will soon change as the number of manufacturers on the continent grows, in part due to PEPFAR and other donors.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. So, when could the goal of a net zero pharmaceutical industry be achieved?